Canada announces new US$59 million contribution to ACT-A

Canada has announced an additional CA$75 million (US$59 million) to the Access to COVID-19 Tools Accelerator (ACT-A), "the global platform created to secure equitable and affordable access to COVID-19 vaccines, tests and treatments". 

This new funding brings Canada's total commitment to ACT-A to CA$940 million (US$744 million).

Canada, to date, has committed approximately CA$2.0 billion (US$1.6 billion) to the global COVID-19 pandemic response.

Press release - Prime Minister of Canada